Jantos C, Krause W, Kauss E, Weidner W
Arbeitsgruppe Erektile Dysfunktion Giessen-Marburg.
Urologe A. 1988 Jan;27(1):18-21.
Long-term experience with intracavernous self-injection of papaverine in 36 patients with erectile failure is reported. The average required dose of papaverine in 2037 documented injections was 31.5 mg. The rate of complications was low with a mean follow-up of 6.9 months. Prolonged erections occurred four times. Two patients reported the development of tolerance. In one man circumscribed induration of the tunica albuginea was observed, which disappeared spontaneously after change of the injection site. No infections of the corpora cavernosa, circulatory disturbances or signs of hepatotoxicity were observed.
报告了36例勃起功能障碍患者海绵体内自我注射罂粟碱的长期经验。在2037次有记录的注射中，罂粟碱的平均所需剂量为31.5毫克。平均随访6.9个月，并发症发生率较低。阴茎异常勃起发生了4次。2例患者报告出现耐受性。在1例男性中观察到白膜局限性硬结，在改变注射部位后自行消失。未观察到海绵体感染、循环障碍或肝毒性迹象。
